NASDAQ: SLNO

Soleno Therapeutics, Inc.

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) resulting from allegations that Soleno Therapeutics may have issued materially misleading business information to the investing public.

If you purchased Soleno Therapeutics securities and would like to join the prospective action, please click “Join This Class Action.”

Retainer Agreement
See Full Details
Join This Class Action
If you purchased Soleno Therapeutics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Contact Us

Details of investigation:

On August 15, 2025, Investing.com published a story entitled “Soleno Therapeutics stock falls after Scorpion Capital short report.” The article stated that Soleno Therapeutics stock had fallen “following a short report from Scorpion Capital that raised serious concerns about the company’s recently approved Prader-Willi syndrome treatment, VYKAT XR.” It further stated that the Scorpion Capital report “highlighted personal safety issues,” and that it “suggested the drug may be at risk of being withdrawn from the market or facing a significant decline in new prescriptions.”

On this news, the price of Soleno Therapeutics stock fell 7.4% on August 15, 2025. It fell a further 4.9% on the next trading day.

Follow us on:
Twitter
Company Name: Soleno Therapeutics Inc.
Stock Symbol: SLNO
Class Period: NASDAQ
Court: SLNO
Share This Class Action
Join This Class Action

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Case Attorneys

image 55 (1)
Phillip Kim

New York, Philadelphia Metro

275 Madison Avenue
40th Floor
New York, NY 10016

Tel: (212) 686-1060
Rosenlegal
Scroll to Top